{
    "nctId": "NCT05488145",
    "briefTitle": "A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy",
    "officialTitle": "A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy",
    "overallStatus": "RECRUITING",
    "conditions": "Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Feasibility (Acceptability)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Early-stage hormone receptor positive, HER2-negative breast cancer who have completed all recommended (neo)adjuvant chemotherapy, surgery and/or radiation therapy\n* Age \\>= 18\n* Started on an aromatase inhibitor or Tamoxifen within less than or equal to six months prior to time of enrollment\n* Access to internet from a desktop or a smartphone\n* Ability to speak English\n\nExclusion Criteria:\n\n* Patients who are her2 neu positive",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}